Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
Clinical trial NCT01992159 · COMPLETED
Trial details
- NCT number
- NCT01992159
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-12
- Primary completion
- 2014-10-09
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.